BGT007 Cells for the Treatment of Refractory Digestive System Tumors
BGT007 Cells for the Treatment of Refractory Digestive System Tumors
Recruiting · NCT06104241 · Registry updated 2023-10-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BGT007 Cells for the Treatment of Refractory Digestive System Tumors | Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, digestive system disorder, digestive system neoplasm, neoplasm | Recruiting | Early phase 1 | 2023-10-27 | NCT06104241 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangzhou Bioresette Biomedical Technology Co., Ltd. | 2 |
| The Affiliated Hospital of Xuzhou Medical University | 68 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| he Affiliated Hospital of Xuzhou Medical University | Xuzhou | China | 1 |